Organization
Shanghai Ninth People's Hospital
8 clinical trials
1 abstract
Abstract
Efficacy and safety of FCN-159, a MEK1/2 inhibitor in pediatric participants with neurofibromatosis type 1: Results from a phase 2 trial.Org: The Children's Hospital of Zhejiang University School of Medicine, NanFang Hospital of Southern Medical University, Shanghai Ninth People's Hospital, Shanghai Fosun Pharmaceutical Industrial Development CO., Ltd.,
Clinical trial
A Phase II Clinical Study of Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable Head and Neck Squamous Cell CarcinomaStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
A Non-randomized Phase II Study of Apatinib and Tegafur Gimeracil Oteracil Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of Head and NeckStatus: Completed, Estimated PCD: 2020-09-30
Clinical trial
A Retrospective Cohort Study on the Long-term Efficacy and Influencing Factors of Physical Therapy for Temporomandibular Joint DisordersStatus: Recruiting, Estimated PCD: 2024-04-06
Clinical trial
Postoperative Radiation and Concurrent Chemotherapy With Weekly Docetaxel Versus Cisplatin in Patients With High-risk Oral Cavity Cancer: a Randomized Phase II Clinical TrialStatus: Completed, Estimated PCD: 2022-02-28
Clinical trial
A Randomized, Controlled, Multicenter Study of Human Adipose Tissue Derived Extracellular Vesicles Promoting Wound HealingStatus: Recruiting, Estimated PCD: 2025-02-28
Clinical trial
Clinical Study of Allogeneic Adipovarian Active Protein in the Treatment of Severe Idiopathic Pulmonary FibrosisStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Cetuximab Plus Dalpicilib in the Second-line Treatment of Patients With HPV Negative, PD-1 Resistant Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: an Open-label,Single Arm,Phase 2 TrialStatus: Recruiting, Estimated PCD: 2024-01-01
Clinical trial
A Prospective, Randomised Controlled, Phase II Clinical Study of Tirilizumab in Combination With Albumin-bound Paclitaxel With Cisplatin for Neoadjuvant and Adjuvant Treatment of Locally Advanced Resectable Oral Squamous Cell CarcinomaStatus: Recruiting, Estimated PCD: 2025-06-19